This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
January 07, 2016
BONESUPPORT™ Announces CERAMENT™ Focused Research Collaboration with Rigshospitalet, Copenhagen University Hospital
January 05, 2016
BONESUPPORT™ Announces Positive Data Highlighting The Use Of CERAMENT™|G In The Management Of Osteomyelitis In The Infected Diabetic Foot
December 21, 2015
Altimmune Announces Presentation at Biotech Showcase 2016
December 21, 2015
Appointment of Mr. Hans Schikan to HealthCap senior advisor
December 17, 2015
Nexstim announces the result of its private placement
December 16, 2015
Strongbridge Biopharma plc Announces Presentation at Biotech Showcase 2016
December 11, 2015
Efficacy Results of Melflufen in Combination with Dexamethasone from an Ongoing Open-Label Phase 2 Study in Patients with Relapsed and RelapsedRefractory Multiple Myeloma (RRMM) Presented at ASH
December 10, 2015
HealthCap Investor Seminar
December 10, 2015
BONESUPPORT™ ANNOUNCES RESULTS OF CERAMENT™|BONE VOID FILLER PROSPECTIVE PILOT STUDY DEMONSTRATING COMPLETE BONE REMODELING IN BENIGN BONE TUMORS
December 10, 2015
First patient enters Phase III TANGO clinical trial to evaluate efficacy to regress atherosclerosis and safety of CER-001 in patients with Familial Primary HypoAlphalipoproteinemia (FPHA)